Female Genital Tumours: WHO Classification of Tumours (Medicine), 5th Edition – An Essential Resource in Tumor Classification
“Female Genital Tumours,” the fourth volume in the 5th edition of the WHO series on the classification of human tumors, is a critical resource for professionals in oncology, pathology, and related fields. As part of the WHO Blue Books series, this edition is recognized as the gold standard in tumor diagnosis and classification. Key features of this book include:
1. Comprehensive Classification: Provides a coherent cancer classification system, organized by anatomical site and structured in a systematic manner.
2. Expertly Prepared: Prepared by 191 authors and editors, with contributions from experts around the world.
3. Updated Content: Reflects the latest developments in histopathology, diagnostic molecular pathology, staging, and diagnostic criteria.
4. Authoritative Reference: Offers indispensable international standards for cancer care and research.
5. High-Quality Images: Features more than 850 high-quality images to aid in diagnosis and understanding.
6. Extensive References: Includes over 3,100 references, providing a robust foundation for research and practice.
7. Targeted Audience: Essential for pathologists, oncologists, cancer researchers, surgeons, epidemiologists, and cancer registrars.
8. Benign to Malignant Listings: Tumors are listed from benign to malignant, providing a comprehensive overview.
9. Practical for Clinical Use: An invaluable tool for diagnosing and treating female genital tumors.
10. Counterfeit Warning: Advises on the importance of purchasing from known sellers to avoid counterfeit copies.
“Female Genital Tumours: WHO Classification of Tumours, 5th Edition” is more than just a medical textbook; it’s an essential guide for the accurate classification and diagnosis of female genital tumors. This volume is fundamental for healthcare professionals committed to the best practices in cancer diagnosis, treatment, and research.
From the book :
Reviews
There are no reviews yet.